Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis.

Eun-Kyu KimAe Kyung ParkEunyoung KoWoong-Yang ParkKyung-Min LeeDong-Young NohWonshik Han

Published in: Breast cancer research and treatment (2019)

The results may provide a promising prognostic tool for predicting chemotherapy responders among TNBC patients prior to initiation of chemotherapeutic treatment.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
genome wide
newly diagnosed
prognostic factors
peritoneal dialysis
squamous cell carcinoma
gene expression
dna methylation
patient reported outcomes
replacement therapy
genome wide identification
smoking cessation